Work

Abstract PS12-20: A dose escalation study of the novel oral SERD-ZN-c5 in women with ER-positive, HER2-negative advanced/metastatic breast cancer

Year: 2021

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs20-ps12-20

Authors: Pavani Chalasani, Vandana Abramson, Joanne Mortimer, Julie R Nangia, Jose Suarez, Matt Suster, Mieke Ptaszynski, Kevin Kalinsky

Institutions: University of Arizona, University of Arizona Cancer Center, Vanderbilt-Ingram Cancer Center, City Of Hope National Medical Center, Baylor College of Medicine, Columbia University Irving Medical Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3131275684

Cites:

Cited by: 3

Related to: 10